Lv4
544 积分 2024-03-26 加入
Transarterial Chemoembolization Plus Thermal Ablation in Unresectable Hepatocellular Carcinoma
22天前
已关闭
Transarterial Chemoembolization Plus Thermal Ablation in Unresectable Hepatocellular Carcinoma
23天前
已完结
GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma
2个月前
已完结
GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma
2个月前
已完结
Outcomes of Y90-radioembolization as downstaging to liver transplantation in patients with hepatocellular carcinoma and tumoral portal vein thrombosis
3个月前
已完结
Reconsidering adjuvant and perioperative immune-checkpoint inhibition: de-escalation, expansion and personalization
3个月前
已完结
Adjuvant nivolumab in muscle-invasive urothelial carcinoma: exploratory biomarker analysis of the randomized phase 3 CheckMate 274 trial
3个月前
已完结
Programmed death ligand 1 expression in hepatocellular carcinoma: Relationship With clinical and pathological features
4个月前
已完结
Prognostic impact of programmed cell death 1 ligand 1 expression in human leukocyte antigen class I-positive hepatocellular carcinoma after curative hepatectomy
4个月前
已完结
Integrative proteogenomic analysis provides molecular insights and clinical significance in gallbladder cancer
4个月前
已完结
皖公网安备34019202002308
